Introducing Pharmaceutical Care to Primary Care in Iceland—An Action Research Study

dc.contributorHáskóli Íslandsen_US
dc.contributorUniversity of Icelanden_US
dc.contributor.authorBlöndal, Anna Bryndís
dc.contributor.authorKälvemark Sporrong, Sofia
dc.contributor.authorAlmarsdóttir, Anna Birna
dc.contributor.departmentLyfjafræðideild (HÍ)en_US
dc.contributor.departmentFaculty of Pharmaceutical Sciences (UI)en_US
dc.contributor.schoolHeilbrigðisvísindasvið (HÍ)en_US
dc.contributor.schoolSchool of Health Sciences (UI)en_US
dc.date.accessioned2017-08-30T11:43:38Z
dc.date.available2017-08-30T11:43:38Z
dc.date.issued2017-04-26
dc.description.abstractEven though pharmaceutical care is not a new concept in pharmacy, its introduction and development has proved to be challenging. In Iceland, general practitioners are not familiar with pharmaceutical care and additionally no such service is offered in pharmacies or primary care settings. Introducing pharmaceutical care in primary care in Iceland is making great efforts to follow other countries, which are bringing the pharmacist more into patient care. General practitioners are key stakeholders in this endeavor. The aim of this study was to introduce pharmacist-led pharmaceutical care into primary care clinics in Iceland in collaboration with general practitioners by presenting different setting structures. Action research provided the framework for this research. Data was collected from pharmaceutical care interventions, whereby the pharmaceutical care practitioner ensures that each of a patient’s medications is assessed to determine if it is appropriate, effective, safe, and that the patient can take medicine as expected. Sources of data included pharmaceutical care notes on patients, researcher’s notes, meetings, and interviews with general practitioners over the period of the study. The study ran from September 2013 to October 2015. Three separate semi-structured in-depth interviews were conducted with five general practitioners from one primary health care clinic in Iceland at different time points throughout the study. Pharmaceutical care was provided to elderly patients (n = 125) before and between general practitioners’ interviews. The study setting was a primary care clinic in the Reykjavik area and the patients’ homes. Results showed that the GPs’ knowledge about pharmacist competencies as healthcare providers and their potential in patient care increased. GPs would now like to have access to a pharmacist on a daily basis. Direct contact between the pharmacist and GPs is better when working in the same physical space. Pharmacist’s access to medical records is necessary for optimal service. Pharmacist-led clinical service was deemed most needed in dose dispensing polypharmacy patients. This research indicated that it was essential to introduce Icelandic GPs to the potential contribution of pharmacists in patient care and that action research was a useful methodology to promote and develop a relationship between those two health care providers in primary care in Iceland.en_US
dc.description.versionPeer Revieweden_US
dc.format.extent23en_US
dc.identifier.citationBlondal AB, Sporrong SK, Almarsdottir AB. Introducing Pharmaceutical Care to Primary Care in Iceland—An Action Research Study. Pharmacy. 2017; 5(2):23. doi:10.3390/pharmacy5020023en_US
dc.identifier.doi10.3390/pharmacy5020023
dc.identifier.issn2226-4787
dc.identifier.journalPharmacyen_US
dc.identifier.urihttps://hdl.handle.net/20.500.11815/373
dc.language.isoenen_US
dc.publisherMDPI AGen_US
dc.relation.ispartofseriesPharmacy;5(2)
dc.relation.urlhttp://www.mdpi.com/2226-4787/5/2/23/pdfen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectPharmacistsen_US
dc.subjectPharmaceutical careen_US
dc.subjectGeneral practitionersen_US
dc.subjectPrimary careen_US
dc.subjectAction researchen_US
dc.subjectLyfjafræðingaren_US
dc.subjectAðhlynningen_US
dc.subjectStarfendarannsókniren_US
dc.titleIntroducing Pharmaceutical Care to Primary Care in Iceland—An Action Research Studyen_US
dc.typeinfo:eu-repo/semantics/articleen_US
dcterms.licenseThis article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).en_US

Skrár

Original bundle

Niðurstöður 1 - 1 af 1
Nafn:
pharmacy-05-00023.pdf
Stærð:
632.72 KB
Snið:
Adobe Portable Document Format
Description:
Publisher´s version (útgefin grein)

Undirflokkur